EFPIA weighs in on supply chain security

1 March 2021
efpia-big-3

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the opportunity to participate in the European Commission’s structured dialogue on supply chain security.

The EFPIA claims that it is critical that any proposals from the structured dialogue take into account the nuances between the different actors across the medicines and vaccines supply chains.

"Europe needs longer-term investment, incentives and global regulatory harmonization in order to build a strong innovative manufacturing and supply ecosystem"EUROSTAT data shows that the European Union (EU) is a strong exporter of pharmaceutical products, and in terms of imports, is resilient because most come from the EU itself, the group stressed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical